Objectives Triple-negative breast cancer (TNBC) is defined as a highly aggressive type of
breast cancer which lacks specific biomarkers and drug targets. Damage-associated …

Purpose Immune checkpoint blockade (ICB) therapy has transformed the treatment of triple-
negative breast cancer (TNBC) in recent years. However, some TNBC patients with high …

Objective: Triple-negative breast cancer (TNBC) is a high heterogeneity cancer. The
identification of genomic aberrations that drive each of the TNBC subtypes may predict the …

Background Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast
cancer and lacks definite treatment targets. Tumor immune microenvironment (TIME) …

Triple-negative breast cancer (TNBC) is characterized by broad genomic and transcriptional
heterogeneity and results in a worse prognosis than other breast cancer types. Here, we …

Simple Summary Triple-negative breast cancer (TNBC) is the most refractory subtype of
breast cancer. Immune checkpoint inhibitor (ICI) therapy has made progress in TNBC …

Background: To classify triple-negative breast cancer (TNBC) immunotyping using the public
database, analyze the differences between subtypes in terms of clinical characteristics and …

Triple-negative breast cancer (TNBC) is a high-risk malignancy due to its high capacity for
invasion and lack of targeted therapy. Immunotherapy continues to demonstrate efficacy in a …

Triple negative breast cancer (TNBC) is an aggressive subtype with limited therapeutic
options. New opportunities are emerging from current comprehensive characterization of …

Breast cancer is a commonly diagnosed female cancer in the world. Triple-negative breast
cancer (TNBC) is the most dangerous and biologically aggressive subtype in breast cancer …